Leit í EES-gagnagrunni
D095325/01
Commission Implementing Regulation (EU) 2024/916 of 26 March 2024 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Proposal for a Regulation of the European Parliament and of the Council amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, information obligation in case of interruption of supply and the transitional provisions for certain in vitro diagnostic medical devices
Commission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devices
Commission Implementing Decision (EU) 2023/2484 of 9 November 2023 amending Implementing Decision 2012/715/EU as regards the inclusion of Taiwan in the list of third countries established by that Decision
C(2023)4568
Commission Delegated Regulation (EU) 2023/2197 of 10 July 2023 amending Regulation (EU) 2017/745 of the European Parliament and of the Council, as regards the assignment of Unique Device Identifiers for contact lenses
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2023/2197 frá 10. júlí 2023 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) 2017/745 að því er varðar úthlutun einkvæmra tækjaauðkenninga fyrir snertilinsur
C(2023)4261
Commission Delegated Regulation (EU) 2023/1766 of 29 June 2023 amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2023/1766 frá 29. júní 2023 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) nr. 658/2014 að því er varðar leiðréttingu á gjöldum, með tilliti til verðbólgu, sem greiða ber til Lyfjastofnunar Evrópu vegna framkvæmdar á lyfjagátarstarfsemi að því er varðar mannalyf
Commission Implementing Regulation (EU) 2023/1194 of 20 June 2023 amending Implementing Regulation (EU) 2022/2346 as regards the transitional provisions for certain products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 of the European Parliament and of the Council
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2023/1194 frá 20. júní 2023 um breytingu á framkvæmdarreglugerð (ESB) 2022/2346 að því er varðar umbreytingarákvæði vegna tiltekinna vara án ætlaðs læknisfræðilegs tilgangs sem eru tilgreindar í XVI. viðauka við reglugerð Evrópuþingsins og ráðsins (ESB) 2017/745
Commission Implementing Regulation (EU) 2023/997 of 23 May 2023 amending Implementing Regulation (EU) 2021/17 establishing a list of variations not requiring assessment in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
Proposal for a Regulation of the European Parliament and of the Council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
Commission Implementing Decision .../... on the authorisation to place on the Union market in accordance with Regulation (EU) 2017/745 of the European Parliament and of the Council certain medical devices manufactured by Maquet Cardiopulmonary GmbH
Commission Regulation (EU) 2023/699 of 29 March 2023 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2023
Reglugerð framkvæmdastjórnarinnar (ESB) 2023/699 frá 29. mars 2023 um breytingu á reglugerð ráðsins (EB) nr. 297/95 að því er varðar leiðréttingu á gjöldum til Lyfjastofnunar Evrópu með tilliti til verðbólgu, sem tekur gildi frá og með 1. apríl 2023
COM(2023) 122
Regulation (EU) 2023/1182 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland and amending Directive 2001/83/EC
Commission Implementing Regulation (EU) 2023/448 of 1 March 2023 amending Implementing Regulation (EU) 2018/574 on technical standards for the establishment and operation of a traceability system for tobacco products
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2023/448 frá 1. mars 2023 um breytingu á framkvæmdarreglugerð (ESB) 2018/574 um tæknistaðla til að koma á fót og starfrækja rekjanleikakerfi fyrir tóbaksvörur
Commission Implementing Decision (EU) 2023/172 of 24 January 2023 amending Implementing Decision 2012/715/EU as regards the inclusion of Canada in the list of third countries established by that Decision
COM(2023) 10
Regulation (EU) 2023/607 of the European Parliament and of the Council of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices
Reglugerð Evrópuþingsins og ráðsins (ESB) 2023/607 frá 15. mars 2023 um breytingu á reglugerðum (ESB) 2017/745 og (ESB) 2017/746 að því er varðar umbreytingarákvæði um tiltekin lækningatæki og lækningatæki til sjúkdómsgreiningar í glasi
C(2022)8649
Commission Delegated Regulation (EU) 2023/503 of 1 December 2022 amending Regulation (EU) 2017/746 of the European Parliament and of the Council as regards the frequency of complete re-assessments of notified bodies
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2023/503 frá 1. desember 2022 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) 2017/746 að því er varðar tíðni heildarendurmata á tilkynntum aðilum
COM(2022) 721
Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95
C(2022)8640
Commission Delegated Regulation (EU) 2023/502 of 1 December 2022 amending Regulation (EU) 2017/745 of the European Parliament and of the Council as regards the frequency of complete re-assessments of notified bodies
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2023/502 frá 1. desember 2022 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) 2017/745 að því er varðar tíðni heildarendurmata á tilkynntum aðilum
C(2022)8335
Commission Delegated Regulation (EU) 2023/183 of 23 November 2022 amending Regulation (EU) 2019/6 of the European Parliament and of the Council as regards the requirements on compliance with good laboratory practice for veterinary medicinal products set out in Annex II to that Regulation
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2023/183 frá 23. nóvember 2022 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) 2019/6 að því er varðar kröfur um að góðum starfsvenjum við rannsóknir sé fylgt fyrir dýralyf sem settar eru fram í II. viðauka við þá reglugerð
C(2022)8440
Commission Delegated Regulation (EU) 2023/196 of 25 November 2022 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2023/196 frá 25. nóvember 2022 um breytingu á reglugerð Evrópuþingsins og ráðsins (EB) nr. 273/2004 og reglugerð ráðsins (EB) nr. 111/2005 að því er varðar að færa tiltekin forefni fíkniefna á skrá yfir skráð efni
D080753/07
Commission Implementing Regulation (EU) 2022/2347 of 1 December 2022 laying down rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards reclassification of groups of certain active products without an intended medical purpose
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2022/2347 frá 1. desember 2022 um reglur um beitingu reglugerðar Evrópuþingsins og ráðsins (ESB) 2017/745 að því er varðar endurflokkun flokka tiltekinna virkra vara án ætlaðs læknisfræðilegs tilgangs
C(2022)6240
Commission Delegated Regulation (EU) 2022/2239 of 6 September 2022 amending Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards labelling requirements for unauthorised investigational and unauthorised auxiliary medicinal products for human use
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2022/2239 frá 6. september 2022 um breytingu á reglugerð Evrópuþingsins og ráðsins (ESB) nr. 536/2014 að því er varðar kröfur um merkingar á rannsóknarlyfjum og aukalyfjum án markaðsleyfis fyrir menn
D080753/04
Commission Implementing Regulation (EU) 2022/2346 of 1 December 2022 laying down common specifications for the groups of products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2022/2346 frá 1. desember 2022 um sameiginlegar forskriftir fyrir flokka vara án ætlaðs læknisfræðilegs tilgangs sem eru tilgreindir í XVI. viðauka við reglugerð Evrópuþingsins og ráðsins (ESB) 2017/745 um lækningatæki
Commission Implementing Decision (EU) 2022/1316 of 25 July 2022 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products
Framkvæmdarákvörðun framkvæmdastjórnarinnar (ESB) 2022/1316 frá 25. júlí 2022 um breytingu á ákvörðun 2008/911/EB um að taka saman skrá yfir jurtaefni, fullbúin jurtalyf og samsetningar þeirra til notkunar í jurtalyf sem hefð er fyrir